Federal contract

VA awarded McKesson Corporation a contract with $1.41B committed so far.

$1.41B
committed so far
Signed
Nov 1, 2025
Updated
Jan 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 18, 2024CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  2. Aug 5, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  3. Sep 10, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  4. Sep 18, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  5. Sep 23, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  6. Oct 8, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  7. Oct 10, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  8. Nov 1, 2025 · this disclosureFederal contract · $1.4B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.41B obligated to date

What came next

  1. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results
  2. Nov 7, 2025InsiderOfficer sold ~$283K of MCK shares in the open market
  3. Nov 18, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  4. Dec 1, 2025Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.11B obligated to date
  5. Dec 2, 2025Congress · 1 personMembers of Congress: 2 purchases
  6. Dec 19, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  7. Jan 1, 2026Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.09B obligated to date
  8. Jan 5, 2026InsiderOfficer sold ~$225K of MCK shares in the open market
  9. Jan 5, 2026Congress · 1 personMembers of Congress: 2 purchases
  10. Jan 16, 2026FDARecall: UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Su…
  11. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  12. Feb 6, 2026InsiderOfficer sold ~$313K of MCK shares in the open market
  13. Feb 10, 2026Layoff notice · 2700 North America Avenue West Seneca, NY, 14224Layoff notice filed in NY: 78 employees
  14. Feb 11, 2026InsiderOfficer sold ~$283K of MCK shares in the open market
  15. Feb 17, 2026InsiderOfficer sold ~$180K of MCK shares in the open market
  16. Feb 19, 2026InsiderDirector sold ~$328K of MCK shares in the open market
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 47 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

How this filing works

Other disclosures at McKesson Corporation

Everything OQRO holds on this company is on its MCK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data